Thrombolytic agent with albumin carrier
This page covers all Thrombolytic agent with albumin carrier drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Fibrin; plasminogen.
Targets
Phase 3 pipeline (1)
- Intra-Arterial TNK and Albumin · Tianjin Huanhu Hospital · Cardiovascular; Neurology
Intra-arterial TNK (tenecteplase) and albumin work together to deliver thrombolytic therapy directly to occluded arteries while albumin may enhance drug delivery and reduce systemic toxicity.
Patent intelligence
- thrombolytic agent with albumin carrier patent landscape — aggregated cliff calendar, attackable patents, originator estates